Drug class
Reversible carbamate acetylcholinesterase inhibitor; centrally acting cholinergic agent
Mechanism of action
Reversibly inhibits acetylcholinesterase, increasing acetylcholine concentrations at central and peripheral cholinergic synapses. This can overcome muscarinic receptor blockade in anticholinergic toxicity.
General use cases
- Reversal of clinically significant central anticholinergic toxicity, particularly delirium, in carefully selected patients under specialist toxicology guidance.
- Ophthalmic use for selected glaucoma indications is historical or jurisdiction- and formulation-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
